CAS

Call Directions Website Contact the organization

CAS CAS is a leader in scientific information solutions and a division of the American Chemical Society. At CAS, our passion is advancing scientific progress.

For over 100 years, scientists, patent professionals, and business leaders have relied on CAS to accelerate breakthroughs and improve lives. As a leader in scientific information solutions, we curate, connect, and analyze the world’s published science to accelerate breakthroughs. CAS Solutions: Connecting research, patent, regulatory, and business professionals to the data and insights they need, our solutions speed progress through each phase of your pipeline. CAS Expertise: Our team of scientists and technologists embody a wealth of experience across disciplines and collectively speak more than 50 languages fueling our unique capabilities and insights. CAS Data: Our scientists curate, connect, and analyze the valuable data disclosed in scientific publications from around the world to build the CAS Content Collection™, covering over 150 years of discoveries. Our Team: Our team of over 1,000 scientists, technologists, and business professionals are passionate about advancing science and collectively speak more than 50 languages. We are proudly headquartered in Columbus, Ohio, with global offices in 45+ countries. Our History: Founded in 1907 as a volunteer effort to organize published chemistry research, CAS officially became a self-supporting division of the American Chemical Society in 1956.

Every day, interrupt their to check other trusted sources and fill gaps in their research. CAS Connections℠ changes ...
10/14/2026

Every day, interrupt their to check other trusted sources and fill gaps in their research. CAS Connections℠ changes that by bringing trusted information into the tools you already use. Learn more: https://bit.ly/4igKGNP

AI-designed cleared strains that had evolved resistance to natural phages. As escalates, -scale generative design...
10/14/2026

AI-designed cleared strains that had evolved resistance to natural phages. As escalates, -scale generative design is opening a new front in the race against resistance. See what this breakthrough signals for R&D strategy: https://bit.ly/4xrnwcR

10/13/2026

What if you could draw a and describe what you need in plain English at the same time? understands both, delivering exact matches without making you choose between search modes. See how it works: https://bit.ly/3UQU55y

This past weekend, we walked to end Alzheimer’s. Thank you to everyone who laced up, donated, and walked with us at the ...
10/13/2026

This past weekend, we walked to end Alzheimer’s. Thank you to everyone who laced up, donated, and walked with us at the Alzheimer's Association Walk to End Alzheimer’s. Every step honors those living with the disease, the families who care for them, and the loved ones we’ve lost. At CAS, we’re proud to help accelerate the search for a cure. Together, we're moving closer to a world without Alzheimer’s.

The CAS and Eli Lilly and Company webinar analyzed 34,000 reactions across 25 years of process , and the audience asked...
10/13/2026

The CAS and Eli Lilly and Company webinar analyzed 34,000 reactions across 25 years of process , and the audience asked what comes next. Our updated article now carries the full Q&A, plus the on-demand recording, slides, and lab notes. Check out the full discussion: https://bit.ly/4ydUnBo

The team examined more than two decades of published process‑scale reactions to explore how the field has evolved, which methodologies dominate at scale, and how strategies have shifted as industry needs have changed.

Last week, The Lawn at CAS glowed for Blood Cancer United Light The Night. Thank you to everyone who walked, donated, an...
10/12/2026

Last week, The Lawn at CAS glowed for Blood Cancer United Light The Night. Thank you to everyone who walked, donated, and carried a lantern. Your support helps advance and for patients and families facing . We're proud to help host this event and to stand with this . Together, we're lighting the way toward a cure.

91% of patients were opioid-free after surgery with a new class of nerve-targeted pain drugs. solar cells are approach...
10/12/2026

91% of patients were opioid-free after surgery with a new class of nerve-targeted pain drugs. solar cells are approaching their theoretical efficiency limit. reproduced a decade of lab in two days. See how 2026 trends are tracking: https://bit.ly/4riji4Y

Five CAS Insights writers revisit our 2026 “Trends to Watch” and discuss their predictions, from nerve-targeted pain relief to AI that helps do the science.

10/09/2026

With , a plain-language search shows you exactly how it was interpreted before you dive into results. Know your search matched your every time. See it in action: https://bit.ly/4h7EAgU

Keyword search alone does not surface every relevant record. Our upcoming shows how search in for CAS IP Finder ...
10/09/2026

Keyword search alone does not surface every relevant record. Our upcoming shows how search in for CAS IP Finder delivers expert-level results without command-line syntax. Register today: https://bit.ly/4AVJNkX

The same abbreviation can mean two entirely different things in different corners of literature. A general-purpose m...
10/09/2026

The same abbreviation can mean two entirely different things in different corners of literature. A general-purpose model that trusts the common meaning is confidently wrong where precision matters most. Read the full recap: https://bit.ly/4h9jJKm

Patent literature is one of the least forgiving places to direct a general-purpose AI. A webinar panel on what breaks, and what curated data changes.

Address

2540 Olentangy River Road
Columbus, OH
43202

Telephone

+16144473600

Website

Alerts

Be the first to know and let us send you an email when CAS posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Organization

Send a message to CAS:

Shortcuts

Share